HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The September-October 1999 issue focuses on challenges and opportunities for individuals with HIV in the workplace. It explores legal protections under the Americans with Disabilities Act (ADA), the psychosocial benefits of returning to work, and strategies for navigating workplace discrimination and accommodations. The issue emphasizes the importance of balancing work with health management, including strict adherence to ART and regular medical appointments. It also discusses vocational training programs, the role of counselors in managing disclosure fears, and accessing government benefits like SSDI and PASS. Additionally, the issue highlights the intersection of tuberculosis and HIV, covering diagnosis, prophylaxis, and treatment challenges.
HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The July-August 2000 issue delves into the complexities of initiating and managing antiretroviral therapy (ART) for people living with HIV. It explores the benefits and risks of early treatment, emphasizing the need for patient readiness and strict adherence to ensure long-term success. Key topics include strategies for minimizing resistance, addressing adherence barriers, and customizing treatment plans based on individual needs. The issue also reviews new ART regimens and highlights their advantages and challenges. Additionally, it covers complications associated with long-term ART, such as mitochondrial toxicity, lipodystrophy, and hepatotoxicity. The publication stresses the critical role of counselors in supporting clients through education, adherence strategies, and holistic care.
HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The February 1999 issue examines the intersection of HIV and addiction, with a focus on addressing the unique challenges faced by injection drug users (IDUs). It highlights the prevalence of co-occurring psychiatric disorders, medical complications such as hepatitis and tuberculosis, and barriers to accessing care. The issue explores models of care, including harm reduction and abstinence-based approaches, emphasizing the importance of compassionate and individualized treatment plans. It also discusses the impact of addiction on adherence to antiretroviral therapy (ART) and strategies to optimize treatment. The publication includes a detailed focus on hepatitis types A, B, and C, addressing their transmission, prevention, and treatment within the context of HIV care.
HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The Spring 1998 issue explores advancements and challenges in HIV treatment. Key topics include emerging antiretroviral therapies (ART), the evolving standard for viral load detection, and updates on investigational drugs like abacavir and efavirenz. It discusses strategies to maximize treatment effectiveness while minimizing toxicity and resistance. The issue also addresses HIV wasting syndrome, its causes, and multifaceted treatment options, including nutritional support, hormone therapy, and mental health interventions. Public health policy debates are highlighted, such as mandatory HIV reporting and needle exchange programs, emphasizing their impact on prevention and care. Overall, the publication provides a comprehensive overview of medical, psychosocial, and policy issues shaping HIV treatment.
HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The Winter 1998 issue discusses the integration of complementary therapies with conventional HIV treatments, emphasizing open communication between clients, counselors, and healthcare providers. It explores various nontraditional approaches, including herbal medicine, acupuncture, massage, and dietary supplements, while warning against fraudulent or harmful practices. The issue also highlights the prevalence, causes, and treatment of candidiasis, a common HIV-related fungal infection. Other updates include trends in AIDS mortality, partner notification policies, and the impact of antiretroviral therapy on conditions like progressive multifocal leukoencephalopathy. The issue stresses a balanced approach to therapy, combining the benefits of complementary methods with proven medical treatments to enhance quality of life for individuals with HIV.
